Levodopa in plasma correlates with body weight of parkinsonian patients
- 1 July 2000
- journal article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 6 (3) , 171-173
- https://doi.org/10.1016/s1353-8020(00)00005-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A levodopa kinetic-dynamic study of the rate of progression in Parkinson's diseaseNeurology, 1998
- The effect of tolcapone on levodopa pharmacokinetics is independent of levodopa/carbidopa formulationZeitschrift für Neurologie, 1998
- Effect of Tolcapone on Plasma Levodopa Concentrations after Coadministration with Levodopa/Carbidopa to Healthy VolunteersClinical Neuropharmacology, 1997
- Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatmentNeurology, 1997
- Free-living Daily Energy Expenditure in Patients with Parkinson's DiseaseNeurology, 1997
- Gastrointestinal Dysfunction in Parkinson's DiseaseSeminars in Neurology, 1996
- Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's diseaseBMJ, 1995
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Selegiline as an Adjunct to Conventional Levodopa Therapy in Parkinson's DiseaseArchives of Neurology, 1989
- Determination of l-DOPA and 3-O-methyl DOPA in human plasma by extraction using C18 cartridges followed by high-performance liquid chromatographic analysis with electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1986